Epic Systems faces U.S. FTC antitrust probe in health data access
Scrutiny is intensifying around how major healthcare technology platforms control access to patient information across the U.S. Epic Systems is facing an antitrust investigation by the U.S. Federal Trade Commission over how it grants or withholds data access and interoperability, according to two sources familiar with the matter.
Highlights
- U.S. Federal Trade Commission has launched an antitrust investigation into Epic Systems, focusing on its medical data access and interoperability practices.
- Epic Systems holds medical records for hundreds of millions of Americans, making the probe significant for national healthcare data infrastructure stability.
- The FTC inquiry highlights regulatory concern that large health records platforms could stifle competition by limiting how easily rivals and partners can connect.
FTC inquiry centers on data access practices
As first reported by Reuters, the U.S. Federal Trade Commission is investigating Epic Systems and has sent investigative demands to other companies in the health technology industry seeking information about the company's handling of data access and interoperability.Epic Systems holds the medical records of hundreds of millions of Americans, making the probe significant for the healthcare data infrastructure that supports hospitals, clinics and digital health providers across the country.
Implications for the health technology sector
The investigation points to regulatory concern over whether large health records platforms can influence competition by controlling how easily rivals and partners connect to their systems. Interoperability has become a central issue in the sector because limits on data sharing can affect software developers, care providers and patients seeking smoother movement of medical information.A spokesperson for the FTC declines to comment. A spokesperson for Epic does not immediately respond to a request for comment.
Our earlier article covered the Operation Gold Rush case, in which U.S. authorities are pursuing a large cross-border healthcare fraud network tied to illicit Medicare and private insurance reimbursements. It highlighted Eldar Zarbavel’s guilty plea to money laundering after allegedly moving about $3.4 million in fraud proceeds through U.S. bank accounts linked to a durable medical equipment company, as investigators continue building the broader case involving massive false claims.
Latest Company News News
-
Afghanistan
-
Albania
-
Algeria
-
Angola
-
Argentina
-
Armenia
-
Australia
-
Austria
-
Azerbaijan
-
Bahamas
-
Bahrain
-
Bangladesh
-
Belarus
-
Belgium
-
Bolivia
-
Botswana
-
Brazil
-
Brunei
-
Bulgaria
-
Cambodia
-
Cameroon
-
Canada
-
Chile
-
China
-
Colombia
-
Congo
-
Costa Rica
-
Cote d'Ivoire
-
Croatia
-
Cuba
-
Cyprus
-
Czechia
-
DR Congo
-
Denmark
-
Dominican Republic
-
Ecuador
-
Egypt
-
El Salvador
-
Estonia
-
Eswatini
-
Ethiopia
-
Finland
-
France
-
Georgia
-
Germany
-
Ghana
-
Greece
-
Haiti
-
Hong Kong
-
Hungary
-
India
-
Indonesia
-
Iran, Islamic republic
-
Iraq
-
Ireland
-
Israel
-
Italy
-
Jamaica
-
Japan
-
Jordan
-
Kazakhstan
-
Kenya
-
Korea
-
Kuwait
-
Kyrgyzstan
-
Laos
-
Latvia
-
Lebanon
-
Lesotho
-
Libya
-
Lithuania
-
Luxembourg
-
Madagascar
-
Malaysia
-
Malta
-
Mauritius
-
Mexico
-
Moldova
-
Mongolia
-
Montenegro
-
Morocco
-
Mozambique
-
Myanmar
-
Namibia
-
Nepal
-
Netherlands
-
New Zealand
-
Nigeria
-
North Macedonia
-
Norway
-
Oman
-
Pakistan
-
Palestine
-
Panama
-
Papua New Guinea
-
Paraguay
-
Peru
-
Philippines
-
Poland
-
Portugal
-
Puerto Rico
-
Qatar
-
Reunion
-
Romania
-
Rwanda
-
Saudi Arabia
-
Serbia
-
Singapore
-
Slovakia
-
Slovenia
-
Somalia
-
South Africa
-
Spain
-
Sri Lanka
-
Sweden
-
Switzerland
-
Syria
-
Taiwan
-
Tajikistan
-
Tanzania
-
Thailand
-
Trinidad and Tobago
-
Tunisia
-
Turkey
-
UAE
-
Uganda
-
Ukraine
-
United Kingdom
-
United States
-
Uruguay
-
Uzbekistan
-
Venezuela
-
Vietnam
-
Yemen
-
Zambia
-
Zimbabwe
- Forex
- Crypto
